Artiva Biotherapeutics (ARTV) Accounts Payables (2023 - 2025)
Historic Accounts Payables for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $848000.0.
- Artiva Biotherapeutics' Accounts Payables fell 3020.58% to $848000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $848000.0, marking a year-over-year decrease of 3020.58%. This contributed to the annual value of $1.1 million for FY2024, which is 8257.33% up from last year.
- Per Artiva Biotherapeutics' latest filing, its Accounts Payables stood at $848000.0 for Q3 2025, which was down 3020.58% from $1.2 million recorded in Q2 2025.
- Over the past 5 years, Artiva Biotherapeutics' Accounts Payables peaked at $2.0 million during Q1 2025, and registered a low of $614000.0 during Q4 2023.
- Its 3-year average for Accounts Payables is $1.1 million, with a median of $1.1 million in 2024.
- In the last 5 years, Artiva Biotherapeutics' Accounts Payables surged by 8257.33% in 2024 and then tumbled by 3020.58% in 2025.
- Over the past 3 years, Artiva Biotherapeutics' Accounts Payables (Quarter) stood at $614000.0 in 2023, then soared by 82.57% to $1.1 million in 2024, then fell by 24.35% to $848000.0 in 2025.
- Its last three reported values are $848000.0 in Q3 2025, $1.2 million for Q2 2025, and $2.0 million during Q1 2025.